ILIAS Biologics Inc.
PrivateLast Round
Series B
Sep 28, 2020
Total Funding Raised
$50.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ILIAS Biologics Inc. operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Series B round in September 2020.
ILIAS Biologics Inc. is a biotechnology company that develops exosome-based therapeutics for inflammatory and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ILIAS Biologics Inc. Comparables
Compare ILIAS Biologics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SHIFTBIO | 86% | |
| Carus Bio | 85% | |
| ExoStemTech | 84% |
For institutional investors. Book with your work email.
ILIAS Biologics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 28, 2020 | ||||
| Series A | May 1, 2018 |
For institutional investors. Book with your work email.
ILIAS Biologics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIWOOM Securities Co., Ltd. | Series B |
| Genie Asset Management | Series B |
| Meritz Securities Co., Ltd. | Series B |
| Timefolio Asset Management | Series A, Series B |
| Daedeok Venture Partners | Series A, Series B |
| HB Investment | Series A, Series B |
| Devsisters Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 125% MoM.
- Jul 20, 2026
Open roles increased from 0 to 9, representing 53% of headcount.
For institutional investors. Book with your work email.
ILIAS Biologics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ILIAS Biologics Inc.'s valuation, stock price, and market status.
Is ILIAS Biologics Inc. a public or private company?
ILIAS Biologics Inc. is a private company.
What is the current stock price of ILIAS Biologics Inc.?
ILIAS Biologics Inc. is a private company, so its shares have no public market price. Caplight tracks ILIAS Biologics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ILIAS Biologics Inc. worth (valuation)?
Valuation information for ILIAS Biologics Inc. is not publicly available.
Can I buy ILIAS Biologics Inc. stock?
ILIAS Biologics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ILIAS Biologics Inc.'s last funding round?
ILIAS Biologics Inc.'s most recent funding round was Series B on September 28, 2020.
Who are the main investors in ILIAS Biologics Inc.?
Key investors in ILIAS Biologics Inc. include KIWOOM Securities Co., Ltd., Genie Asset Management, Meritz Securities Co., Ltd., Timefolio Asset Management, Daedeok Venture Partners.
Will ILIAS Biologics Inc. IPO soon?
No public IPO plans have been announced for ILIAS Biologics Inc..
How can I track ILIAS Biologics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ILIAS Biologics Inc.'s shares on secondary markets.